Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Dodd

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Brain Research. Brain Research Protocols|April 17, 2003
Quantitation of NMDA receptor NR2 mRNA transcripts in human brain by competitive RT-PCRMatthew R Hynd, Heather L Scott, Peter R Dodd
Neurochemistry International|July 6, 2004
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's diseaseMatthew R Hynd, Heather L Scott, Peter R Dodd
Brain Research. Brain Research Protocols|April 17, 2003
Quantitation of alternatively spliced NMDA receptor NR1 isoform mRNA transcripts in human brain by competitive RT-PCRMatthew R Hynd, Heather L Scott, Peter R Dodd
Progress in Neurobiology|March 9, 2011
Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's diseaseDustin T Proctor, Elizabeth J Coulson, Peter R Dodd
Journal of Neurochemistry|August 4, 2004
Differential expression of N-methyl-D-aspartate receptor NR2 isoforms in Alzheimer's diseaseMatthew R Hynd, Heather L Scott, Peter R Dodd
Journal of Alzheimer'S Disease : JAD|July 17, 2010
Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathologyDustin T Proctor, Elizabeth J Coulson, Peter R Dodd
Journal of Neurochemistry|March 20, 2004
Selective loss of NMDA receptor NR1 subunit isoforms in Alzheimer's diseaseMatthew R Hynd, Heather L Scott, Peter R Dodd
Drug Metabolism Reviews|August 9, 2016
Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugsFrancesca Toselli, Peter R Dodd, Elizabeth M J Gillam
Neurobiology of Aging|November 12, 2013
Role for the neurexin-neuroligin complex in Alzheimer's diseaseIkhlas A Sindi, Rudolph K Tannenberg, Peter R Dodd
Journal of Neurochemistry|June 18, 2002
Spermine modulation of the glutamate(NMDA) receptor is differentially responsive to conantokins in normal and Alzheimer's disease human cerebral cortexLotten Ragnarsson, Martin Mortensen, Peter R Dodd, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Brain Research. Brain Research Protocols|April 17, 2003
Quantitation of NMDA receptor NR2 mRNA transcripts in human brain by competitive RT-PCRMatthew R Hynd, Heather L Scott, Peter R Dodd
Neurochemistry International|July 6, 2004
Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's diseaseMatthew R Hynd, Heather L Scott, Peter R Dodd
Brain Research. Brain Research Protocols|April 17, 2003
Quantitation of alternatively spliced NMDA receptor NR1 isoform mRNA transcripts in human brain by competitive RT-PCRMatthew R Hynd, Heather L Scott, Peter R Dodd
Progress in Neurobiology|March 9, 2011
Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's diseaseDustin T Proctor, Elizabeth J Coulson, Peter R Dodd
Journal of Neurochemistry|August 4, 2004
Differential expression of N-methyl-D-aspartate receptor NR2 isoforms in Alzheimer's diseaseMatthew R Hynd, Heather L Scott, Peter R Dodd
Journal of Alzheimer'S Disease : JAD|July 17, 2010
Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathologyDustin T Proctor, Elizabeth J Coulson, Peter R Dodd
Journal of Neurochemistry|March 20, 2004
Selective loss of NMDA receptor NR1 subunit isoforms in Alzheimer's diseaseMatthew R Hynd, Heather L Scott, Peter R Dodd
Drug Metabolism Reviews|August 9, 2016
Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugsFrancesca Toselli, Peter R Dodd, Elizabeth M J Gillam
Neurobiology of Aging|November 12, 2013
Role for the neurexin-neuroligin complex in Alzheimer's diseaseIkhlas A Sindi, Rudolph K Tannenberg, Peter R Dodd
Journal of Neurochemistry|June 18, 2002
Spermine modulation of the glutamate(NMDA) receptor is differentially responsive to conantokins in normal and Alzheimer's disease human cerebral cortexLotten Ragnarsson, Martin Mortensen, Peter R Dodd, et al.
Pageof 7